Exp Neurobiol April 2025 PMID 40234095

Magnesium-L-threonate Ameliorates Cognitive Deficit by Attenuating Adult Hippocampal Neurogenesis Impairment in a Mouse Model of Alzheimer's Disease.

Ying Xiong, Yuwen Yang, Yuting Ruan, Wencai Ou, Zhiwen Hu, Wei Li, Nina Xiao, Wang Liao, Jianhua Liu, Zhenlu Liu, Qiong Luo, Feifei Liu, Jun Liu

Full text PDF Download social card

Mentions

Peak: 2 in Oct 2025

across 3 sources since Apr 2025

Extended reach

248,243

potential audience

Total likes

8,389

Video views

248,244

Mentions per month

Apr 2025 – Dec 2025

Where it's discussed

YouTube3 videos
News2 articles
Bluesky1 posts

AI synopsis

What people are saying

Discussions highlight the promising nature of magnesium threonate in Alzheimer’s treatment, with statements like 'potential breakthrough' and 'activates key pathways,' indicating a high level of interest and engagement. The tone is generally positive and analytical, with some users referencing specific biological mechanisms to underscore the significance of the findings.

AgreementModerate agreement

Most discussions reflect approval or acknowledgment of the research's potential benefits, with some emphasizing the importance of neurogenesis in treating Alzheimer's.

InterestHigh interest

The topic of cognitive improvement and mechanisms of neurogenesis attracts high interest, as seen in comments praising the study's significance.

EngagementModerate engagement

Posts show active engagement, referencing specific cellular pathways like ERK and CREB, and discussing implications for future therapies.

ImpactModerate impact

Though impactful, many discussions focus on the scientific relevance rather than immediate clinical application, suggesting moderate perceived impact.

Abstract in brief

This study investigates whether magnesium threonate (MgT) can improve memory problems in an Alzheimer's disease mouse model by promoting the growth of new neurons in the hippocampus, an area important for learning and memory.
The results showed that MgT treatment increased the formation of new neurons and improved memory performance, likely by activating specific cellular pathways (ERK and CREB) that support neuron growth and survival.
However, when an ERK inhibitor was used, these positive effects were reduced, suggesting that MgT works through the ERK-CREB signaling pathway to help counteract neurogenesis impairment and cognitive deficits in Alzheimer's disease.

Read the full abstract